Evidence map›Paper›PMID 35005466›Full record

ArticleIJU case reports2022

Granulocyte colony-stimulating factor associated arteritis in a patient with castration-resistant prostate cancer.

Satoshi Nitta, Takazo Tanaka, Ryota Yanagihashi, Haruna Nonaka, Shuhei Suzuki, Tomokazu Kimura, Shuya Kandori, Akio Hoshi, Hiromitsu Negoro, Hiroyuki Nishiyama

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IJU case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Satoshi NittaDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0000-0002-2855-1061
Takazo TanakaDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Ryota YanagihashiDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Haruna NonakaDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Shuhei SuzukiDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Tomokazu KimuraDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Shuya KandoriDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0000-0003-4621-8470
Akio HoshiDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Hiromitsu NegoroDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Hiroyuki NishiyamaDepartment of Urology Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
University of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGranulocyte colony-stimulating factor-associated arteritis is a rare adverse event of granulocyte colony-stimulating factor, with an incidence of 0.47% among all patients who receive granulocyte colony-stimulating factor. We herein present a case of granulocyte colony-stimulating factor-associated arteritis. CASE PRESENTATION: A 72-year-old man with castration-resistant prostate cancer and multiple bone metastases was treated with docetaxel and pegfilgrastim. He developed a high fever on day 12 without other symptoms. His white blood cell count and C-reactive protein levels were high. Antibiotic therapy was ineffective, and contrast-enhanced computed tomography showed thickened subclavian and brachiocephalic artery walls. He was diagnosed with granulocyte colony-stimulating factor-associated arteritis.

conclusionWhen patients receiving chemotherapy with granulocyte colony-stimulating factor develop an unexplained fever, granulocyte colony-stimulating factor associated arteritis should be considered.

Indexed as

arteritiscastration‐resistant prostate cancerdocetaxelgranulocyte colony‐stimulating factorprednisolone

Identifiers

PMID35005466
PMCPMC8720713
OpenAlexW3201152123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.